ArticleScientific reports2026
Application and characterization of the multiple instance learning framework in flow cytometry.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cannabinoid receptor expression profiling in lymphocyte subsets reveals clinically relevant immune patterns in SLE.Frontiers in immunology · 2026Article
- Immune monitoring for relapse of acute myeloid leukemia after allogeneic stem cell transplantation in clinical laboratories.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For decades, flow cytometry has allowed for single-cell profiling based on selected biomarkers and is widely used in both clinical and research settings. One major limitation of most conventional flow cytometry analyses is the dependency on a mostly manual gating process. This generally involves sequentially selecting biomarkers to isolate phenotype-associated cell populations, an approach that is both labor-intensive and prone to bias. To address this challenge, we introduce the application of a series of multi-instance learning frameworks for automated flow cytometry data analysis. Our models demonstrate strong performance across diverse biomedical applications, including cancer subtyping based on tumor-infiltrating immune cells, HIV survival stratification, AML minimal residual disease prediction, and COVID-19 severity assessment. We further examine how network architecture affects predictive performance and the detection of rare but clinically significant cell populations. Notably, our models utilize attention mechanisms to directly identify phenotype-associated cell subsets, serving as an interpretable, data-driven alternative to fully manual gating. These findings underscore the potential of multi-instance learning as a scalable and interpretable framework for flow cytometry, with broad applications in precision medicine and translational immunology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.